Letter in reply: Linear IgA bullous dermatosis treated with dupilumab in a pediatric patient with glucose-6-phosphate dehydrogenase deficiency

Letter in reply: Linear IgA bullous dermatosis treated with dupilumab in a pediatric patient with glucose-6-phosphate dehydrogenase deficiency

Bibliographic Details
Main Authors:	Sonal Muzumdar, MD, Lorin A. Bibb, MD, Brett Sloan, MD, Michael Murphy, MD, Mary Wu Chang, MD
Format:	Article
Language:	English
Published:	Elsevier 2024-02-01
Series:	JAAD Case Reports
Subjects:	chronic bullous dermatosis of childhood dupilumab linear IgA bullous dermatosis pediatric dermatology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512623004472

Similar Items

Linear IgA bullous dermatosis
by: L. F. Znamenskaya, et al.
Published: (2019-04-01)

A histopathological overlap of linear IgA bullous dermatosis and vasculitis
by: Tharani Murali, MHS, et al.
Published: (2025-02-01)

Linear IgA/IgG bullous dermatosis successfully treated with omalizumab: A case report
by: Morten Bahrt Haulrig, et al.
Published: (2022-03-01)

Atypical bullous systemic lupus erythematosus with features of linear IgA bullous dermatosis
by: Roy Jiang, MD, PhD, et al.
Published: (2025-04-01)

Linear IgA bullous dermatosis induced by atezolizumab: a case report
by: Seba Almutairi, et al.
Published: (2024-02-01)

Case report: Dupilumab: a promising treatment option for adult linear IgA bullous dermatosis with severe pruritus
by: Li Wang, et al.
Published: (2024-08-01)

Research progress on linear IgA bullous dermatosis
by: Mei WU, et al.
Published: (2023-12-01)

Linear IgA and IgG bullous dermatosis
by: Karina de Almeida Pinto Fernandes, et al.
Published: (2016-10-01)

Revisiting the “jelly-roll” technique: New utility in diagnosing linear IgA bullous dermatosis mimicking toxic epidermal necrolysis
by: Samavia Khan, BS, et al.
Published: (2023-11-01)

Linear IgA bullous dermatosis secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system
by: Yixuan Yang, et al.
Published: (2025-01-01)

Linear IgA bullous dermatosis induced by nemvaleukin alfa, an engineered interleukin 2 molecule, in a patient with treatment-refractory metastatic melanoma
by: Fatima Bawany, MD, et al.
Published: (2023-11-01)

Rituximab for linear IgA bullous dermatosis
by: Rummit Dhillon, et al.
Published: (2022-12-01)

A case of linear IgA bullous dermatosis in a glucose-6-phosphate dehydrogenase–deficient child successfully treated with oral erythromycin and topical tacrolimus
by: Michelle Ann Ramos, MD, et al.
Published: (2023-02-01)

Adult linear IgA bullous dermatosis: report of three cases
by: Taila Yuri Siqueira Machado, et al.
Published: (2018-06-01)

New Onset and Exacerbation of Autoimmune Bullous Dermatosis Following COVID-19 Vaccination: A Systematic Review
by: Po-Chien Wu, et al.
Published: (2024-04-01)

Vancomycin and linear IgA bullous dermatosis
by: Amr Ismail, et al.
Published: (2018-01-01)

Development of cyclosporine-induced linear IgA bullous dermatosis despite concurrent use of dapsone
by: Karissa Libson, BA, et al.
Published: (2023-10-01)

Association of recalcitrant scabies infestation and bullous pemphigoid in an infant
by: Thilo Gambichler, et al.
Published: (2024-06-01)

Linear Immunoglobulin a Bullous Dermatosis in Children
by: Francesca Mori, et al.
Published: (2022-07-01)

Case Report: Prurigo nodularis-like linear IgA/IgG bullous dermatosis: a case report and literature review
by: Yuxi Zhou, et al.
Published: (2023-05-01)

Dupilumab in acquired perforating dermatosis: A potential new treatment
by: Musaed M. Alsebayel, MD, et al.
Published: (2022-10-01)

Penfigoide bolhoso no lactente e seu principal diagnóstico diferencial: dermatose bolhosa por IgA linear
by: Luciana Silva de Godoy, et al.
Published: (2023-06-01)

Toxic epidermal necrolysis-like linear IgA bullous dermatosis after third Moderna COVID-19 vaccine in the setting of oral terbinafine
by: Joseph Han, BS, et al.
Published: (2022-06-01)

Clinical and Immunological Study of 30 Cases With Both IgG and IgA Anti-Keratinocyte Cell Surface Autoantibodies Toward the Definition of Intercellular IgG/IgA Dermatosis
by: Takashi Hashimoto, et al.
Published: (2018-05-01)

Linear IgA bullous dermatosis and elevated bullous interleukin‐6 levels: Responsive to treatment with Anti‐IL‐6 receptor monoclonals
by: Stanley C. Jordan, et al.
Published: (2023-02-01)

Dapsone-responsive inflammatory dermatitis with features of subcorneal pustular dermatosis and bullous pemphigoid
by: Shilpa Ghatnekar, MS, et al.
Published: (2022-06-01)

Radiotherapy-induced localized bullous pemphigoid with a favorable response to dupilumab
by: Chanidapa Wongtada, MD, et al.
Published: (2024-06-01)

Linear IgA bullous dermatosis–a fifty year experience of Warsaw Center of bullous diseases
by: Cezary Kowalewski, et al.
Published: (2025-01-01)

Mixed immunobullous disease in infants: Falls in bullous pemphigoid-linear IgA spectrum?
by: Sruthi Mohanan, et al.
Published: (2020-01-01)

Successful treatment of linear immunoglobulin A bullous dermatosis with dupilumab in a pediatric patient
by: Nouf Almuhanna, MD, et al.
Published: (2023-08-01)

Linear IgA bullous dermatosis: a clinical study of 16 cases at National Taiwan University Hospital
by: I-Chen Tsai, et al.
Published: (2010-03-01)

Successful treatment of subcorneal pustular dermatosis targeting an underlying monoclonal IgA gammopathy
by: Ina Kreyberg, MD, PhD, et al.
Published: (2023-11-01)

Recalcitrant bullous pemphigoid responsive to dupilumab in an adolescent patient
by: Albert E. Zhou, MD, PhD, et al.
Published: (2022-11-01)

Acquired perforating dermatosis successfully treated with dupilumab
by: Omar Alwattar‐Ceballos, et al.
Published: (2023-12-01)

Dermatosis por IgA lineal asociada a semaglutida
by: Yolanda Juan-García, et al.
Published: (2020-11-01)

Immune checkpoint inhibitor induced bullous pemphigoid treated by dupilumab: A case series
by: Emily Bogdanski, BS, et al.
Published: (2025-03-01)

Research progress on the treatment of bullous pemphigoid with Dupilumab
by: LUO Xiaojia, et al.
Published: (2024-08-01)

Assessing the use of dupilumab in a pediatric patient with bullous congenital ichthyosiform erythroderma
by: Nouf Almuhanna, MD, et al.
Published: (2023-09-01)

Conceptualization and validation of an innovative direct immunofluorescence technique utilizing fluorescein conjugate against IgG + IgG4 for routinely diagnosing autoimmune bullous dermatoses
by: Magdalena Danuta Jałowska, et al.
Published: (2021-06-01)

Effect of Dupilumab on Generalized Verrucosis in Refractory Bullous Pemphigoid
by: Qijun Wang, et al.
Published: (2023-09-01)